Supreme Court Seeks Snapdeal's Response in Prescription Drug Sale Case
Introduction
The Supreme Court has sought a response from Snapdeal and its directors after the Karnataka government challenged a Karnataka High Court judgment that had quashed criminal proceedings related to the alleged online sale of a Schedule H prescription medicine without a valid licence or a doctor's prescription. The case raises important legal questions about the responsibilities of e-commerce marketplaces when third-party sellers are accused of violating drug regulations.
Background
The dispute relates to the alleged sale of Suhagra-100, a Schedule H prescription medicine used for the treatment of erectile dy
...
